The synthesis and biological evaluation of a series of 4(3H)-quinazoli
nones substituted at the 6-position with isoxazolines and isoxazolidin
es is described. Of these, compound 25a was found to be an especially
potent, orally active, non-competitive angiotensin II receptor antagon
ist.